Effect of insulin on cell growth and virus production

Improving influenza and adenovirus yield with the addition of insulin for vaccine production

One of the challenges in the vaccine industry is to produce large quantities of vaccines in a rapid and cost-effective way.

Major changes to current bioprocesses are difficult to implement due to costs associated with the regulatory approval process. Therefore, we propose to use insulin, a growth factor currently used and approved in several processes and production platforms, as an additive to boost cell growth, productivity and viral yield.

Click here for more information

Featured Companies

Novo Nordisk Pharmatech (more information, website)